Attached files
| file | filename |
|---|---|
| EX-32 - EX-32 - EXACT SCIENCES CORP | exas-20201231xexx32.htm |
| EX-31.2 - EX-31.2 - EXACT SCIENCES CORP | exas-20201231xexx312.htm |
| EX-31.1 - EX-31.1 - EXACT SCIENCES CORP | exas-20201231xexx311.htm |
| EX-23.2 - EX-23.2 - EXACT SCIENCES CORP | exas-20201231xexx232.htm |
| EX-21 - EX-21 - EXACT SCIENCES CORP | exas-20201231xexx21.htm |
| EX-10.25 - EX-10.25 - EXACT SCIENCES CORP | exas-20201231xex1025.htm |
| EX-10.17 - EX-10.17 - EXACT SCIENCES CORP | exas-20201231xexx1017.htm |
| EX-10.16 - EX-10.16 - EXACT SCIENCES CORP | exas-20201231xexx1016.htm |
| EX-4.6 - EX-4.6 - EXACT SCIENCES CORP | exas-20201231xex46.htm |
| 10-K - 10-K - EXACT SCIENCES CORP | exas-20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-190350; No.333-207703; No. 333-211099; No. 333-212730; No. 333-219553; No. 333-229780; No. 333-232916; No. 333-219553; No. 234608; and No. 333-251900) and Form S-3 (No. 333-238845) of Exact Sciences Corporation of our report dated February 16, 2021 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Chicago, Illinois
February 16, 2021
1